We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Statins Reduce Cardiovascular Risk Following Irradiation

By MedImaging International staff writers
Posted on 15 Aug 2019
Cancer patients taking statins following radiation therapy (RT) of the upper body had significantly reduced risk of stroke and other cardiovascular complications, according to a new study.

Researchers at McGill University (Montreal, Canada), Walter Reed National Military Medical Centre (Washington DC, USA), and other institutions conducted a retrospective cohort study involving 5,718 cardiac patients with thorax and head or neck cancer who underwent RT between 2000 and 2011; of these, 1,552 did not use statins, while 4,166 did. The primary outcome was a composite of transient ischemic attack (TIA), fatal or nonfatal stroke, or fatal or nonfatal myocardial infarction (MI).

After adjusting for age, sex, prior history of stroke/TIA or MI, diabetes mellitus, dyslipidemia, atrial fibrillation (AF), chronic kidney disease (CKD), heart failure (HF), and hypertension, statin use following RT was associated with a nonsignificant 15% relative risk reduction, but a strong trend toward reducing the primary outcome, and especially with a significant reduction of 32% for the outcome of stroke alone. The study was published on July 2, 2019, in Journal of the American Heart Association.

“Statins decrease cholesterol levels and have anti-inflammatory properties. Statins are protective in patients with heart disease, previous strokes, and with high cholesterol levels,” said senior author Negar Mousavi, MD, MHSc, of McGill University Health Center. “Our study demonstrated that statin therapy could be favorable even with the competing risks of cancer and cancer-related mortality in patients who received radiation therapy.”

While RT is an effective treatment for many different types of cancers, the net clinical benefit of RT is mitigated by an increased risk of cardiovascular and cerebrovascular diseases, including ischemic stroke, TIA, carotid stenosis, and MI. The mechanism of action is incompletely understood, but appears to be independent of conventional vascular risk factors, with data suggesting a key role for inflammation and accelerated atherosclerosis. The pattern of plaque generation within affected arteries appears to be distinct from that generated solely by traditional atherosclerosis.

Related Links:
McGill University
Walter Reed National Military Medical Centre

Biopsy Software
Affirm® Contrast
Portable X-ray Unit
AJEX140H
X-ray Diagnostic System
FDX Visionary-A
Digital Color Doppler Ultrasound System
MS22Plus

Channels

General/Advanced Imaging

view channel
Image: A multinational study reports that AI can quickly generate clinically acceptable radiotherapy plans across care settings (Photo courtesy of Adobe Stock)

AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer

Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.